Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / COLL - Collegium Pharmaceutical GAAP EPS of -$0.73 misses by $1.08 revenue of $27.36M misses by $54.17M

COLL - Collegium Pharmaceutical GAAP EPS of -$0.73 misses by $1.08 revenue of $27.36M misses by $54.17M

Collegium Pharmaceutical Inc.
Collegium Pharmaceutical press release (NASDAQ:COLL): Q4 GAAP EPS of -$0.73 misses by $1.08. Revenue of $27.36M (-64.1% Y/Y) misses by $54.17M. 2022 Revenue Guidance of $315-$330 Million, Growth Driven by Xtampza ER. Full-Year Net Income of $71.5 Million and Full-Year Adjusted EBITDA of $118.3 million. Cash Balance of $186.4 Million

For further details see:

Collegium Pharmaceutical GAAP EPS of -$0.73 misses by $1.08, revenue of $27.36M misses by $54.17M
Stock Information
Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com
Menu
COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...